Skip to main content
. 2021 Feb 28;13(5):1008. doi: 10.3390/cancers13051008

Table 4.

Oncological and reproductive outcome after FSS in patients with cervical, ovarian, and endometrial cancer.

Cervical Cancer Ovarian Cancer Endometrial Cancer
LLETZ/CKC/ST VRT ART
Laparotomic MIS
Oncological outcome *
Recurrence 28/785 (3.6) 82/1973 (4.2) 47/1520 (3.1) 15/335 (4.5) 171/1084 (15.7) 297/855 (34.7)
Died of disease 6/785 (0.8) 34/1973 (1.7) 23/1520 (1.5) 7/479 (1.5) 489/3318 (14.7) 5/648 (0.8)
Complete response 736/918 (80.2)
Persistent disease 182/918 (19.8)
PR 16/504 (3.2)
SD 52/504 (10.3)
PrD 28/504 (5.6)
Follow-up in months, 53 (9–137) 52 (9–131) 47 (12–120) 44 (10–98) 66 (38–143) 56 (17–92)
median (range)
Fertility outcome *
Pregnancy wish ^ 148/305 (48.5) 599/1089 (55.0) 510/1062 (48.0) 71/199 (35.7) 148/335 (44.2) 279/446 (62.6)
Pregnancies ^ 241/612 (39.4) 707/1539 (45.9) 353/1635 (21.6) 81/344 (23.5) 280/750 (37.3) 256/505 (50.7)
Pregnant patients ^ 196/665 (29.5) 512/1392 (36.8) 255/1427 (17.9) 58/317 (18.3) 207/701 (29.5) 261/708 (36.9)
Pregnancy rate # 82/138 (59.4) 361/546 (66.1) 212/471 (45.0) 42/71 (59.2) 110/148 (74.3) 161/241 (66.8)
Fetal loss ~ 36/234 (15.4) 147/686 (21.4) 101/407 (24.8) 19/81 (23.5) 17/191 (8.9) 67/214 (31.3)
Termination ~ 7/234 (3.0) 26/686 (3.8) 20/407 (4.9) 0/81 (0) 3/191 (1.6) 0/214 (0)
Live birth ~ 181/234 (77.4) 484/686 (70.6) 236/407 (58.0) 58/81 (71.6) 236/264 (89.4) 172/239 (72.0)
Term delivery $ 111/181 (61.3) 262/484 (54.1) 80/236 (33.9) 26/58 (44.8) 161/164 (98.2) 82/93 (88.2)
Preterm delivery $ 27/181 (14.9) 146/484 (30.2) 109/236 (46.2) 32/58 (55.2) 3/164 (1.8) 9/93 (9.7)
Not specified 43 76 47 0 72 79
Pregnancy ongoing 10 20 25 4 7 2

n/total (%); ^ total patients; # total patients with pregnancy wish who succeeded; ~ total pregnancies; $ total live births; LLETZ—large loop excision of the transformation zone; CKC—cold knife conization; ST—simple trachelectomy; VRT—vaginal radical trachelectomy; ART—abdominal radical trachelectomy; MIS—minimal invasive surgery (laparoscopic or robot-assisted); PR—partial response; SD—stable disease; PrD—progressive disease; * Limited to publications with available data.